Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 164 resultados

QtCilia: A Novel Glutamine Q Sensory Role for Primary Cilia Implications for Health and Disease OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: ERC-2023-ADG Primary cilia are single, microtubule-based, organelles protruding as antennae at the surface of most cells. Their dysfunction is associated...
2024-10-07 - 2029-10-31 | Financiado

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

UNION: UnderstandiNg fraIlty tOwards a future of healthy ageiNg With falling birth rates and increasing life expectancy we are an ageing society. 20% of boys and 25% of girls born in 2019 are expected to...
2024-07-01 - 2028-12-31 | Financiado

MIRACLE: Integrated multi angle research and training network to eradicate leukemia minimal residual disease An estimated 300,000 new cases of leukemia are diagnosed each year globally. The most common form of acute leukemia is acute myeloid leukemi...
2024-06-28 - 2028-11-30 | Financiado

LAMA2-TFIMG: Tackling fibrosis and inflammation in LAMA2-RD by in vivo modulation of a novel modifier gene OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Merosin-deficient congenital muscular dystrophy (LAMA2-RD) is caused by mutations in the LAMA2 gene, coding for the α2 subunit of laminin-21...
2024-04-24 - 2026-12-31 | Financiado

MOD-REG: Modulating Tregs in liver disease for therapeutic benefit OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: HORIZON-MSCA-2023-PF-01 Regulatory T cells (Tregs) are important for maintaining tolerance to self and are known to contribute to appropriate priming in the case of...
2024-03-15 - 2026-04-30 | Financiado

B-Path: Breath Pathogen Detection (B-Path): Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis... OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 Respiratory infections resulted in >7 million deaths in 2020 and were responsible for 7 of the last 9 pandemics, causing trillions of €s in...
2023-12-11 - 2028-06-30 | Financiado

ENDEAVOR: Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for de... OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 In many European countries the recent rise in incidence of esophageal adenocarcinoma (EAC) is without precedent. EAC is notorious for its h...
2023-12-11 - 2028-12-31 | Financiado

PolArt: Neuromorphic Polariton Accelerator OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 Exciton-polaritons, hybrid light-matter particles, have recently come into the spotlight for their peculiar properties (sizable interaction,...
2023-11-21 - 2028-01-31 | Financiado

BreathForDx: Establishing Exhaled Breath Aerosol (XBA) sampling for diagnosis and screening of respiratory infect... OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-07 Respiratory infections resulted in >7 million deaths in 2020 and were responsible for 7 of the last 9 pandemics, causing trillions of €s in...
2023-10-14 - 2026-12-31 | Financiado

S-CAM: Spirocyclic CAMs as novel and ultrapotent anti-HBV drugs (S-CAM) OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: ERC-2023-POC This PoC project aims to advance the development of next-generation direct-acting antivirals (DAAs) against hepatitis B virus (HBV), namely...
2023-09-25 - 2025-03-31 | Financiado

PHIRE: Photoacoustic imaging and artificial intelligence-based theranostic approach for cancer OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 "Health programs crave for diagnostic imaging and eradication of chemoresistant neoplastic lesions smaller than 1 mm of size. PHIRE, based o...
2023-09-01 - 2026-08-31 | Financiado

MABank: Creation of a GLP bank of immune-privileged, immortal mesoangioblasts to treat monogenic, recessive... OSPEDALE SAN RAFFAELE SRL tramitó un HORIZON EUROPE: ERC-2023-POC Stem cells led to effective cures for diseases of blood and epithelia. However, in the case of diseases affecting muscles, connective tissue...
2023-08-31 - 2025-02-28 | Financiado

MEFHISTO: Decoding and targeting the PGE2-MEF2A axis in tumor-associated macrophages OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: ERC-2022-COG Inflammation is a complex spectrum of processes whose outcomes range from cell killing to tissue regeneration. In this context, a major goal...
2023-05-30 - 2028-08-31 | Financiado

IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... OSPEDALE SAN RAFFAELE SRL participó en un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado

OSR